Cytek Biosciences, Inc. (CTKB) Misses Q1 EPS by 7c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. SPY
9. XYZ
10. FISV

Go back to Cytek Biosciences, Inc. (CTKB) Misses Q1 EPS by 7c

Cytek Biosciences Reports First Quarter 2023 Financial Results

May 9, 2023 4:05 PM EDT

FREMONT, Calif., May 09, 2023 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (Cytek Biosciences or Cytek) (Nasdaq: CTKB) today reported financial results for the first quarter ended March 31, 2023.

First Quarter Highlights

Total revenue was $37.1 million, or $38.1 million on a constant currency basis, representing 6% and 9% increases respectively, over the first quarter of 2022. Organic revenue for Cyteks existing product portfolio was $33.7 million in the first quarter of 2023, representing a decline of 4% compared to the... More